- News
- Ibrance
Tag:
Ibrance
-
Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its experimental oral breast cancer drug giredestrant failed to show effectiveness in newly diagnosed patients.09 Mar 2026-13:54
-